.
MergerLinks Header Logo

Announced

Completed

Legend Capital led a $224m Series C funding round in GenScript ProBio.

Financials

Edit Data
Transaction Value£183m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Single Bidder

Cross Border

Private Equity

Completed

Minority

Private

Friendly

Venture Capital

Hong Kong

Pharmaceuticals

pharmaceutical research

Acquisition

Synopsis

Edit

Legend Capital, an investment firm based in Beijing, led a $224m Series C funding round in GenScript ProBio, a pharmaceutical research and manufacturing service provider, with participation from HighLight Capital and Xiamen C&D. The capital raising will help build up manufacturing capacity, further research and development capabilities and opportunistically acquire assets to develop its Contract Development and Manufacturing Organization business GenScript Biotech said.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US